Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)
McCaughan, G. W., Thwaites, P. A., Roberts, S. K., Strasser, S. I., Mitchell, J., Morales, B., Mason, S., Gow, P., Wigg, A., Tallis, C., Jeffrey, G., George, J., Thompson, A. J., Parker, F. C., Angus,Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.14404
Date:
December, 2017
File:
PDF, 618 KB
english, 2017
File converter
More search results
More benefits 
